Studii clinice pentru Gliom în Ohio
18 studii pentru Gliom caută participanți în Ohio.
Orașe în Ohio
Text oficial al studiului (în engleză)
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- Children's Hospital Medical Center of Akron, Akron
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Rainbow Babies and Childrens Hospital, Cleveland
- și încă 3
În curs de recrutareFaza 1/2
12 Months – 21 Years · Toate sexele · Actualizat 1 oct. 2026 · NCT05099003Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Cleveland Clinic Taussig Cancer Center, Cleveland
- Ohio State University, Columbus
În curs de recrutareFaza 2
Vârste de 18 ani și peste · Toate sexele · Actualizat 28 sept. 2026 · NCT07326566ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
- Cincinnati Children's Hospital, Cincinnati
- Nationwide Children's Hospital, Columbus
În curs de recrutareFaza 2
12 Months – 39 Years · Toate sexele · Actualizat 21 sept. 2026 · NCT06838676Development of MRF for Characterization of Brain Tumors After Radiotherapy
- University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland
- Cleveland Clinic Taussig Cancer Center, Cleveland
În curs de recrutareVoluntari sănătoși bineveniți
Vârste de la 18 la 60 · Toate sexele · Actualizat 15 sept. 2026 · NCT06101069Targeted Pediatric High-Grade Glioma Therapy
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
În curs de recrutareStudiu observațional
12 Months – 39 Years · Toate sexele · Actualizat 8 sept. 2026 · NCT05839379Study of Olutasidenib and Temozolomide in HGG
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
În curs de recrutareFaza 2
Vârste de la 12 la 39 · Toate sexele · Actualizat 1 sept. 2026 · NCT06161974SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Cleveland Clinic, Cleveland
În curs de recrutareFaza 3
Vârste de 18 ani și peste · Toate sexele · Actualizat 28 aug. 2026 · NCT05303519PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
În curs de recrutareFaza 2
Vârste de la 3 la 39 · Toate sexele · Actualizat 24 aug. 2026 · NCT05096481Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland
În curs de recrutareFaza 1
Vârste de 18 ani și peste · Toate sexele · Actualizat 6 aug. 2026 · NCT05565118A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Nationwide Children's Hospital, Colombus
- The Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
- Taylor Cancer Research Center, Maumee
În curs de recrutareFaza 2
Vârste de 8 ani și peste · Toate sexele · Actualizat 27 iul. 2026 · NCT05503797Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
- Ohio State University Medical Center, Columbus
În curs de recrutare
Vârste de la 18 la 85 · Toate sexele · Actualizat 21 iul. 2026 · NCT06910306Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
În curs de recrutareFaza 1/2
Vârste de la 4 la 39 · Toate sexele · Actualizat 20 iul. 2026 · NCT05278208Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
În curs de recrutareFaza 1 timpurieVoluntari sănătoși bineveniți
Vârste de la 1 la 21 · Toate sexele · Actualizat 29 iun. 2026 · NCT06333899Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
În curs de recrutareFaza 2
12 Months – 39 Years · Toate sexele · Actualizat 29 mai 2026 · NCT05843253Anti-GARP Chimeric Antigen Receptor T Cell Therapy for the Treatment of Recurrent Grade III or IV Gliomas
- Ohio State University Comprehensive Cancer Center, Columbus
În curs de recrutareFaza 1
Vârste de 18 ani și peste · Toate sexele · Actualizat 8 mai 2026 · NCT06964737Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Ohio State University Comprehensive Cancer Center, Columbus
În curs de recrutareFaza 1/2
Vârste de 18 ani și peste · Toate sexele · Actualizat 13 apr. 2026 · NCT06810544A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
În curs de recrutareFaza 1 timpurie
Până la vârsta de 21 · Toate sexele · Actualizat 18 mar. 2026 · NCT04655404Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells
- Nationwide Children's Hospital, Columbus
În curs de recrutareFaza 1
12 Months – 39 Years · Toate sexele · Actualizat 13 mai 2025 · NCT04254419Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.